PP2A modulation overcomes multidrug resistance in chronic lymphocytic leukemia via mPTP-dependent apoptosis
Targeted therapies such as venetoclax (VEN) (Bcl-2 inhibitor) have revolutionized the treatment of chronic lymphocytic leukemia (CLL). We previously reported that persister CLL cells in treated patients overexpress multiple antiapoptotic proteins and display resistance to proapoptotic agents. Here,...
Main Authors: | Kallesh D. Jayappa, Brian Tran, Vicki L. Gordon, Christopher Morris, Shekhar Saha, Caroline C. Farrington, Caitlin M. O’Connor, Kaitlin P. Zawacki, Krista M. Isaac, Mark Kester, Timothy P. Bender, Michael E. Williams, Craig A. Portell, Michael J. Weber, Goutham Narla |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical Investigation
2023-07-01
|
Series: | The Journal of Clinical Investigation |
Subjects: | |
Online Access: | https://doi.org/10.1172/JCI155938 |
Similar Items
-
Promising Strategy of mPTP Modulation in Cancer Therapy: An Emerging Progress and Future Insight
by: Mohammad Waseem, et al.
Published: (2023-03-01) -
Identification of Phosphorylated Calpain 3 in Rat Brain Mitochondria under mPTP Opening
by: Yulia Baburuna, et al.
Published: (2021-09-01) -
Extracellular acidification induces ROS- and mPTP-mediated death in HEK293 cells
by: José Teixeira, et al.
Published: (2018-05-01) -
Myocardial Adaptation in Pseudohypoxia: Signaling and Regulation of mPTP via Mitochondrial Connexin 43 and Cardiolipin
by: Miroslav Ferko, et al.
Published: (2019-11-01) -
Discovery of a new mitochondria permeability transition pore (mPTP) inhibitor based on gallic acid
by: José Teixeira, et al.
Published: (2018-01-01)